I. Implementation of clinical staging examination before surgery, chemotherapy or radiotherapy.
ii. clear pathological diagnosis before chemotherapy or radiotherapy.
III. Probing and recording the tumor site, size and infiltration of lymph nodes around the liver, pelvis and major blood vessels during surgery; Zhang Mao, Department of General Surgery, Baotou Central Hospital
(iv) Pathological examination using 10% neutral formalin buffer.
V. The pathology report of the resected lesion should include the gross view of the tumor, differentiation, depth of infiltration and the cut edge and choroidal nerve infiltration; the pathology report after radical surgery should include the number of biopsied lymph nodes and the number of positive lymph nodes.
VI. implementation of Kras gene testing prior to the application of targeted drug therapy.
vii. radiotherapy should record the target area, technique and dose
viii. middle and lower rectal cancer of T3 and/or N+ should receive standardized preoperative or postoperative radiotherapy
ix. the indications for chemotherapy and protocol selection for advanced colorectal cancer are in accordance with the specifications
x. Efficacy evaluation should be implemented after chemotherapy for advanced colorectal cancer.
xi. adverse reaction evaluation should be implemented after chemotherapy and radiotherapy
xii. providing health education for patients on colorectal cancer
XIII. The number of days patients are hospitalized and hospitalization costs.